View Larger Taking meds before exposure cuts HIV risk for heterosexuals
An ounce of prevention is worth a pound of cure!
Science Finds!
View Larger 
Drug designer: New tool reveals mutations that cause HIV-drug resistance
Above: A stick model of HIV’s aspartyl protease enzyme, a common target for many HIV drugs on the market. Our lab focuses on HIV’s reverse transcriptase instead.
NRTIs May Cause Premature Aging In People With HIV →
As someone who does research with NRTI’s, it’s really interesting to see how they affect the human body outside of the target organelle.
Also, inaugural post!
